Renal cell carcinoma (RCC) is a lethal urological cancer, and high mortality rates associated with the disease are frequently due to late diagnosis and the functional diversity of a tumor. Current diagnostic paradigms, mostly depending on radiological visualization and histopathological evaluation, are plagued with problems in the form of inter-observer variation and lag time in detection, and are also inadequate in recapitulating the heterogeneous nature of the tumor microenvironment. To address these challenges, in this work we propose an intelligent diagnostic framework combining quantumenhanced expandable neural networks (Q-ENNs) and medical imaging for precision oncology. In contrast to traditional DL models, Q-ENNs leverage quantum parallelism and entanglement-induced strategies to traverse high-dimensional imaging spaces by outperforming feature extraction and diagnostic performance. The scalable design can flexibly scale network layers and qubits according to clinical requirements, allowing multi-stage RCC diagnosis. Q-ENNs trained on multimodal imaging data (including CT, MRI, and histopathological slides) outperform state-of-theart convolutional neural networks (CNNs) in the tasks of tumor detection, staging, and subtype classification. In addition, the quantum-assisted optimization approach accelerates the convergence and alleviates local minima, which are not only benefit for better discrimination performance but also robust diagnostic results among different populations of patients. We validate our results by clinical evaluation, where a better trade-off between sensitivity and specificity with higher interpretability are obtained with respect to state-of-the-art through explainable quantum feature mapping, as claimed in precision oncology terms. The system we present is intended to be deployed in a realistic clinical setting, supporting computational performance (scalability), integration in the existing radiology workflow, and generic imaging modalities. By interfacing principles of quantum computing with clinical applications, this study paves the road for the future of oncology diagnostics. These discoveries underpin that quantum-driven diagnostic systems could change the way RCC is assessed, providing for earlier and more reliable detection, help in the personalization of treatment and thus enhance patient outcomes in precision oncology.
Renal cell carcinoma (RCC) is a lethal urological cancer, and high mortality rates associated with the disease are frequently due to late diagnosis and the functional diversity of a tumor. Current diagnostic paradigms, mostly depending on radiological visualization and histopathological evaluation, are plagued with problems in the form of inter-observer variation and lag time in detection, and are also inadequate in recapitulating the heterogeneous nature of the tumor microenvironment. To address these challenges, in this work we propose an intelligent diagnostic framework combining quantumenhanced expandable neural networks (Q-ENNs) and medical imaging for precision oncology. In contrast to traditional DL models, Q-ENNs leverage quantum parallelism and entanglement-induced strategies to traverse high-dimensional imaging spaces by outperforming feature extraction and diagnostic performance. The scalable design can flexibly scale network layers and qubits according to clinical requirements, allowing multi-stage RCC diagnosis. Q-ENNs trained on multimodal imaging data (including CT, MRI, and histopathological slides) outperform state-of-theart convolutional neural networks (CNNs) in the tasks of tumor detection, staging, and subtype classification. In addition, the quantum-assisted optimization approach accelerates the convergence and alleviates local minima, which are not only benefit for better discrimination performance but also robust diagnostic results among different populations of patients. We validate our results by clinical evaluation, where a better trade-off between sensitivity and specificity with higher interpretability are obtained with respect to state-of-the-art through explainable quantum feature mapping, as claimed in precision oncology terms. The system we present is intended to be deployed in a realistic clinical setting, supporting computational performance (scalability), integration in the existing radiology workflow, and generic imaging modalities. By interfacing principles of quantum computing with clinical applications, this study paves the road for the future of oncology diagnostics. These discoveries underpin that quantum-driven diagnostic systems could change the way RCC is assessed, providing for earlier and more reliable detection, help in the personalization of treatment and thus enhance patient outcomes in precision oncology.
Renal Cell Carcinoma (RCC) is a leading tumour of the kidney and among most common cancer in adults. 30-40% is often diagnosed when already (in) advanced stage, since there is no specific symptoms, but earliest for these patients infancy detection of RCC. This case emphasizes the importance of precise diagnosis from cellular to tubular-epithelial-lining kidney level that results in successful management and good prognosis. Cryofocus and quantum therapy on the background of modern achievements of artificial intelligence and quantum computers in medical attention Recent achievements of Artificial Intelligence (AI) and quantum computer technologies, and medical visualization are solving some problems experienced by the classic methods of treatment long ago. In this paper, we propose a novel quantum networks model (QNM) by AI which joins the quantum enhanced neural computation with high optical resolution medical imaging data for diagnosis of RCC. Here we have shown a quantum version of an innovation for image recognition in which the pixels are not the fundamental unit of the model, but qubits are. G can now learn to represent finer textures, e.g., complex visual patterns that description which is not directly described by CNNs. Pre-processed images from classical computing (histopathological slides, contrast enhanced CT scans) were input to a quantum-classically hybrid system. This architecture features encoding with quantum circuits and variational quantum layers, which learn complex relationships between RCC types of features and epithelial tissue morphology. Our experiments also demonstrate for the first time, the superiority of our hybrid quantum neural model over the classical deep learning methods in various computational sub-tasks of renal tissue anomaly diagnosis — segmentation, classification and grading. Comprehensive validation on heavily curated large-scale datasets consistently shows significantly better accuracy, sensitivity and specificity, which can be in orders of magnitudes, challenging classical models especially in regions where they diverge. Feedback from expert clinicians (oncologists and pathologists) indicates very good correlation of quantum-based features to pathological RCC biomarkers. Their work is a step toward something that kills so many people each year, and something vastly more accurate and efficient to diagnose. Quantum AI, medical imaging and combination are part of an era-defining decision-supporting system. It might mean earlier detection, less false positives and better outcomes for RCC patients. This model is sector independent and can be generalised to other cancer types and imaging modalities as well.
Cancer remains a major global health challenge, necessitating the development of accurate, scalable, and clinically reliable diagnostic approaches. Artificial intelligence (AI) has significantly enhanced cancer detection through advanced analysis of medical imaging, histopathology, and multi-omics data. However, conventional AI models face limitations related to computational scalability, optimization complexity, and data heterogeneity. Quantum computing introduces a fundamentally different computational paradigm based on superposition, entanglement, and probabilistic state evolution. The integration of quantum computing with machine learning referred to as Quantum Artificial Intelligence (QAI) has emerged as a promising approach to address these challenges. This review critically evaluates the role of QAI in cancer detection through a systematic analysis of literature published between 2015 and 2026. The findings suggest that QAI can enhance feature representation, accelerate optimization processes, and improve predictive performance. Hybrid quantum-classical models show potential in tumor classification, multi-omics integration, and real-time clinical decision-making. Despite these advances, significant challenges remain, including hardware limitations, lack of large-scale validation, and ethical concerns. Overall, QAI represents a promising yet emerging paradigm with potential to transform early cancer detection and precision oncology. This review uniquely synthesizes quantum-AI approaches in oncology, emphasizing hybrid quantum-classical models as the most practical translational pathway for clinical adoption.
Quantum-Enhanced Machine Learning (QEML) is a new computational paradigm that introduces the concept of quantum mechanics with the latest artificial intelligence algorithms to enhance the performance of the diagnostic process in the field of medical imaging. The early identification of diseases is crucial in mortality reduction and improving patient outcome, especially in capacities dealing with such diseases as cancer, neurological diseases, heart diseases, and infections of the lungs. Although conventional deep learning architectures, in particular, Convolutional Neural Networks (CNNs) have been highly successful in processing complex medical images such as MRI scans, CT images, X-rays, and histopathological data, they can be computationally expensive, need large data sets, and suffer in optimization of high dimensional feature spaces. The limitations that QEML tries to overcome are based on the quantum mechanical principles of superposition, entanglement and interference to facilitate better data representation and processing. The suggested structure is based on the classical deep learning architectures and variational quantum circuits together, to create a hybrid quantum-classical system, which improves features extraction and classification levels. Under this method, the classical image characteristics are coded into quantum states and processed in high-dimensional Hilbert spaces, which can enhance the separability of subtle disease patterns, which would have otherwise been challenging to obtain with conventional techniques. The objective of this hybrid system is to enhance the critical diagnostic measures like sensitivity and specificity without affecting the interpretability of such measures to be used in the clinical context. The proposed framework is also assessed in terms of its feasibility, its computational performance and scalability to the capabilities of present-day Noisy Intermediate-Scale Quantum (NISQ) devices. The model effectiveness is evaluated using objective evaluation metrics, which, in a way, guarantee the feasibility of the model application within a real-life healthcare context. On balance, quantum computing and medical image analysis integration is an exciting field of work of the future intelligent healthcare systems and has a potential of providing more efficient, accurate, and scalable diagnostic solutions.
Quantum Convolutional Neural Networks (QCNNs) have became a promising field for quantum advantage in feature extraction and classification of different datasets like Handwritten datasets, Fashion datasets, particularly useful for complex datasets like medical images. Medical image classification has emerged as a critical component in modern healthcare diagnostics, particularly for tumor detection and cancer diagnosis. Normally, Classical CNN is used for image classification but they may face certain challenges in achieving further improvements in accuracy, computational efficiency, processing time. Also, it becomes difficult to train for high-dimensional medical datasets and extracting complex feature representations. Therefore, In this proposal, Image classification through a Scalable and Resource efficient QCNN is proposed which integrates classical CNN with quantum computing. This review examines the current state of medical image classification for tumor detection, analyzes the transition from classical CNNs to quantum-based architectures, and explores the potential of QCNNs in revolutionizing medical diagnostics. This research includes QCNN architecture which will include selective feature encoding using encoding technique such as Z Feature map and quantum circuits for convolutional layers and pooling layers to handle multi-modal medical data (e.g., MRI and CT scans). We aim to achieve superior accuracy with reduced parameters over classical CNNs. This work advances quantum ML toward practical deployment in resource-limited healthcare settings.
The advent of quantum computing has introduced significant potential to revolutionize healthcare through quantum neural networks (QNNs), offering unprecedented capabilities in processing and analyzing multimodal medical data. Traditional computational methods, including classical machine learning models, face challenges when handling the complex, high-dimensional, and often heterogeneous nature of medical data. Quantum neural networks, leveraging quantum mechanics’ fundamental principles, provide a robust framework capable of handling such data with enhanced accuracy and efficiency. This paper investigates the transformative role of QNNs in healthcare diagnostics, treatment pathway optimization, and long-term prognostic analytics, emphasizing their potential to elevate current medical practices to new heights. We begin by providing an overview of the theoretical foundation of quantum computing and the specific mechanisms by which quantum neural networks operate, detailing the principles of quantum superposition, entanglement, and quantum parallelism. These principles empower QNNs to perform computations that are infeasible for classical counterparts, thereby paving the way for deeper, multidimensional insights into patient data. The integration of QNNs into healthcare presents opportunities for significantly enhancing diagnostic accuracy, particularly when analyzing multimodal inputs such as medical images, genomic data, electronic health records, and physiological signals. The capability of QNNs to operate on qubits, which can exist in multiple states simultaneously, enables them to identify complex patterns that classical models may overlook. Through the use of quantum circuits designed for classification and regression tasks, QNNs can facilitate more precise disease identification, including rare conditions that require intricate data synthesis for accurate diagnosis. Moreover, the inherent parallelism of quantum algorithms allows for faster data processing, which could lead to more timely diagnoses and better patient outcomes. This paper delves into the practical application of QNNs in devising and optimizing treatment pathways. The precision with which QNNs analyze patient-specific data can inform personalized medicine approaches, guiding tailored treatment plans based on real-time patient feedback and evolving clinical parameters. We explore how QNNs can leverage their ability to integrate diverse data sources—such as genetic information, medical history, and lifestyle factors—to model patient responses to different treatments with a higher degree of accuracy. This modeling is essential for predicting potential drug interactions, side effects, and overall efficacy, leading to improved patient care by minimizing trial-and-error approaches and reducing healthcare costs. Long-term prognostic analysis, a critical component of chronic disease management and preventive healthcare, also stands to benefit from the integration of quantum neural networks. By synthesizing longitudinal data and identifying temporal trends, QNNs can uncover latent predictive factors that influence the progression of diseases. The paper presents an analysis of how QNNs can provide accurate predictions for patient outcomes over extended periods, taking into account not only individual health records but also epidemiological data and environmental influences. This type of analysis can assist healthcare providers in developing proactive care strategies that are both more effective and resource-efficient. The potential of QNNs to enhance prognostic assessments is not limited to predicting survival rates but extends to forecasting disease remission and recurrence patterns, contributing to informed decision-making in clinical settings. The paper further highlights current challenges and limitations in implementing QNNs in practical healthcare scenarios. These include technological constraints such as qubit coherence times, quantum error correction, and the scalability of quantum algorithms. The integration of quantum hardware with classical infrastructure also poses significant hurdles, requiring robust hybrid systems that can bridge the gap between quantum and classical data processing. We examine ongoing research efforts aimed at overcoming these challenges, including advancements in quantum algorithm development, quantum hardware improvements, and the development of hybrid quantum-classical architectures that can maximize computational power while mitigating current limitations. Furthermore, ethical considerations related to patient data privacy and security are scrutinized, given the novel nature of quantum computing and the sensitivity of medical data. Ensuring data security in quantum-enhanced healthcare systems is paramount, as the encryption methods that safeguard classical systems may not be sufficient against quantum threats. We discuss the integration of quantum cryptography techniques that can complement QNN applications, providing a comprehensive approach to data protection that aligns with healthcare regulations. This paper concludes by outlining future directions for quantum neural network applications in healthcare. The potential for QNNs to revolutionize the field hinges not only on advancements in quantum hardware but also on the development of interdisciplinary research and collaboration between quantum physicists, computer scientists, and healthcare professionals. The roadmap for widespread adoption includes education and training to equip healthcare practitioners with the necessary skills to work with quantum-enhanced systems, as well as strategic partnerships aimed at integrating quantum technologies into existing healthcare infrastructures. The implications for global health are profound, as quantum neural networks stand to make healthcare more accessible, efficient, and personalized. By transforming diagnostics, optimizing treatment pathways, and providing predictive insights, QNNs could catalyze a paradigm shift in the way medical services are delivered, enhancing both the quality of care and patient outcomes on a global scale.
Breast cancer is one of the most prevalent and life-threatening diseases affecting women worldwide, and early detection plays a crucial role in improving survival rates and treatment outcomes.Conventional diagnostic methods such as mammography, ultrasound imaging, and histopathological analysis rely heavily on expert interpretation and classical machine learning techniques.Although classical deep learning models, especially Convolutional Neural Networks (CNNs), have demonstrated impressive performance in medical image analysis, they face inherent limitations related to computational complexity, scalability, and the curse of dimensionality when handling large, high-resolution datasets.With the rapid advancement of quantum computing, Quantum Machine Learning (QML) has emerged as a promising paradigm capable of addressing these challenges by leveraging quantum phenomena such as superposition and entanglement.This research explores the application of Quantum Convolutional Neural Networks (Quantum CNNs or QCNNs) for breast cancer detection, aiming to enhance classification accuracy while reducing computational overhead.The proposed approach integrates quantum circuits with classical preprocessing techniques to extract discriminative features from breast cancer datasets, such as mammographic or histopathological images.By encoding image features into quantum states and performing convolution operations through parameterized quantum circuits, the Quantum CNN model is designed to learn complex patterns more efficiently than classical counterparts.The study evaluates the effectiveness of Quantum CNNs in distinguishing between benign and malignant breast tumors and compares its performance with traditional CNN models.The findings highlight the potential of Quantum CNNs to revolutionize medical image analysis by offering faster convergence, improved generalization, and robustness against noise.This research contributes to the growing field of quantumassisted healthcare systems and demonstrates how quantum computing can be harnessed to address critical challenges in breast cancer diagnosis.